YCYajnaseni Chakraborti

Yajnaseni Chakraborti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yajnaseni Chakraborti has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exposure to Fine Particulate Matter During Pregnancy and Postpartum Psychological Functioning in the ECHO Cohort: Effect Modification by Body Mass Index

    by Yueh-Hsiu Mathilda Chiu, Brent A. Coull, Hsiao-Hsien Leon Hsu, Ander Wilson, Itai Kloog, Heather E. Volk, Courtney K. Blackwell, Akhgar Ghassabian, Lyndsay A. Avalos, Alexis Whitman, et al.

  • Open Access

    Preconception Mycoplasma genitalium Seropositivity and Risk of Impaired Fecundity

    by Yajnaseni Chakraborti, Stefanie N Hinkle, Jørgen Skov Jensen, John F Alderete, Catherine L Haggerty, Toni Darville, Sunni L Mumford, Enrique F Schisterman, Robert M Silver, Anna Overgaard Kildemoes, et al.

    Background: Mycoplasma genitalium (MG) is an emerging sexually transmitted infection (STI) associated with pelvic inflammatory disease. Its relationship with impaired fecundity remains unclear and is rarely examined in the context of co-seropositivity with other STIs. Methods: We conducted a secondary analysis of the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial, a prospective preconception cohort of women with proven fecundity and prior pregnancy loss. Mycoplasma genitalium serostatus was determined using Western blot–based immunoglobulin G assays on 1146 stored serum specimens. Chlamydia trachomatis (CT) and other STIs were also measured. Associations between MG seropositivity and measures of impaired fecundity were assessed. Pregnancy loss and live birth were modeled using inverse-probability weighted quasi-Poisson and unweighted log-binomial models to calculate relative risks (RRs). Fecundability odds ratio (FOR) was estimated using a discrete Cox proportional hazards model accounting for left truncation and right censoring. Propensity score (PS)-weighted versions of these models assessed risks associated with CT co-seropositivity. Analyses were adjusted for demographic and reproductive history variables. Results: Overall, 17.1% (n = 210) of participants were MG seropositive, with 27.6% (n = 58) co-seropositive with CT. Compared with STI-seronegative women, MG seropositivity was not associated with any outcome, although trends were observed for reduced fecundability (FORadj: 0.87, 95% confidence interval [CI] .70–1.08) and live birth (RRadj: 0.94, 95% CI .79–1.11). Co-seropositivity with CT was associated with lower likelihood of live birth (RRPS-weighted: 0.82, 95% CI .70–.96). Sensitivity analyses supported the robustness of these findings. Conclusions: Being co-seropositive for MG and CT preconception was associated with impaired fecundity.

  • Open Access

    Weight Change Between Pregnancies and Mortality Over 50 Years of Follow‐Up

    by Yajnaseni Chakraborti, Sunni L. Mumford, Edwina H. Yeung, Katherine L. Grantz, Pauline Mendola, James L. Mills, Ellen C. Caniglia, Colleen M. Brensinger, Cuilin Zhang, Enrique F. Schisterman, et al.

    Objective: This study aimed to evaluate the link between postpartum weight retention (PPWR) and long‐term mortality. Methods: In this secondary analysis of 8165 women with ≥ 2 pregnancies in the Collaborative Perinatal Project (CPP), U.S., 1959–1966, with vital status follow‐up through 2016, we used interconception weight change (ICWC) and interpregnancy weight change (IPWC) as proxies of PPWR. ICWC was defined as the difference between self‐reported pre‐pregnancy weight from the 1st and 2nd CPP pregnancies, while IPWC was the difference between weight recorded at delivery of the 1st and pre‐pregnancy weight of the 2nd CPP pregnancies. All‐cause and cause‐specific mortality models were adjusted for sociodemographic, behavioral, clinical, and pregnancy‐related characteristics from the 1st CPP pregnancy. Results: Compared to women with ICWC > 0 to 1.8 kg (quintile 3), those with ICWC > −1.4 to 0 kg (quintile 2) had a lower risk of all‐cause mortality (aHR [95% CI]: 0.85 [0.76–0.96]), with the most notable reduction observed in diabetes‐related risk of mortality (aHR [95% CI]: 0.45 [0.23–0.87]). Lower quintiles of IPWC (i.e., greater weight loss) were suggestive of reduced all‐cause and cause‐specific risk of mortality, though the estimates were not statistically significant. Conclusions: Minimizing PPWR was linked to reduced mortality risk over 50 years of follow‐up.


  • Open Access

    Target Trial Emulation for Non-Pharmaceutical Interventions: Methodological Challenges and Solutions

    by Jessica J. Wong, Julia D. DiTosto, Yajnaseni Chakraborti, Stefanie N. Hinkle, Sunni L. Mumford, Enrique F. Schisterman, Ellen C. Caniglia

    Purpose of Review: Target trial emulation is a methodological framework designed to emulate hypothetical randomized controlled trials using observational data, particularly when conducting actual trials is unethical or infeasible. Non-pharmaceutical interventions, such as dietary patterns, physical activity, and environmental exposures, require unique methodological considerations for target trial emulation compared to pharmaceutical interventions. In this review, we aim to familiarize researchers with the key methodological challenges involved in emulating target trials of non-pharmaceutical interventions and to offer evidence-based recommendations for addressing these challenges. Recent Findings: We outline the fundamental assumptions necessary for valid causal inference when emulating a target trial: consistency, exchangeability, and positivity. We examine why these assumptions are particularly challenging to uphold for non-pharmaceutical interventions compared to pharmaceutical exposures. Next, we review recent work on non-pharmaceutical interventions studied using target trial emulation and highlight five methodological challenges that threaten the validity of causal assumptions: ill-defined interventions, intervention heterogeneity, uncommon or infeasible strategies, unclear time zero, and periodic measurement with sustained adherence assumptions. We map each challenge to specific components of the target trial protocol. To demonstrate how these challenges manifest in practice, we present a case study of maternal dairy intake and risk of child allergies and conclude with practical recommendations for mitigating each challenge. Summary: The framework and strategies outlined in this review will enable researchers to rigorously apply target trial emulation to non-pharmaceutical interventions, shifting the focus from documenting associations to estimating causal effects and strengthening the role of observational research in guiding evidence-based population health research.


  • Open Access

    Preconception Mycoplasma genitalium Seropositivity and Risk of Impaired Fecundity

    by Yajnaseni Chakraborti, Stefanie N. Hinkle, Jørgen Skov Jensen, Anna Overgaard Kildemoes, Catherine L. Haggerty, Toni Darville, Sunni L. Mumford, Enrique F Schisterman, Robert M. Silver, John F. Alderete, et al.

    Background: Mycoplasma genitalium (MG) is an emerging sexually transmitted infection (STI) associated with pelvic inflammatory disease and tubal factor infertility. Its relationship with impaired fecundity remains unclear and is rarely examined in the context of co-seropositivity with other STIs. Methods: We conducted a secondary analysis of the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial, a prospective preconception cohort of women with proven fecundity and prior pregnancy loss. MG serostatus was determined using Western blot–based IgG assays on 1146 stored serum specimens. Chlamydia trachomatis (CT) and other STIs were also measured. Associations between MG seropositivity and measures of impaired fecundity were assessed. Pregnancy loss and live birth were modeled using inverse-probability weighted quasi-Poisson and unweighted log-binomial models to calculate relative risks (RR). Fecundability-odds-ratio (FOR) was estimated using a discrete Cox proportional hazards model accounting for left truncation and right censoring. Propensity score (PS) weighted versions of these models assessed risks associated with CT co-seropositivity. Analyses were adjusted for demographic and reproductive history variables. Results: Overall, 17.1% (n=210) of participants were MG seropositive, with 27.6% (n=58) co-seropositive with CT . Compared to STI-seronegative women, MG seropositivity was not associated with any outcome, although trends were observed for reduced fecundability (FOR adj : 0.87, 95% CI 0.70-1.08) and live birth (RR adj : 0.94, 95% CI 0.79-1.11). Co-seropositivity with CT was associated with lower likelihood of live birth [Relative Risk (RR) PS-weighted : 0.82, 95% CI: 0.70-0.96]. Sensitivity analyses supported the robustness of these findings. Conclusions: Being co-seropositive for MG and CT preconception may impair fecundity.

  • Time-Varying Path-Specific Direct and Indirect Effects: A Novel Approach to Examine Dynamic Behavioral Processes with Application to Smoking Cessation

    by Yajnaseni Chakraborti, Recai M. Yucel, Megan E. Piper, Jeremy Mennis, Anthony J. Alberg, Timothy B. Baker, Donna L. Coffman

    Behavioral processes are often complex, and vary over time, requiring intensive longitudinal data to effectively capture the dynamic elements involved. For example, examining daily socio-behavioral and treatment adherence data collected during a smoking quit attempt, can reveal how, when, and why withdrawal symptoms change, offering insight into critical windows of relapse-risk in the cessation process. However, analytical methods (e.g., time-varying causal mediation methods), that can translate such intensive longitudinal data into time-varying causal effects remain limited, hindering a deeper understanding of these dynamic behavioral processes. We propose a new approach, augmented mediational g-formula with a two-step estimation strategy, to estimate time-varying causal (in)direct effects. Its performance was evaluated via simulation, comparing bias, precision, and alignment with the product-of-coefficients approach. The optimal approach identified by the simulation study was applied to data from the Wisconsin Smokers' Health Study II, for assessing the effect of randomized pharmacological treatment assignment (exposure) on daily smoking cessation outcome(s), mediated via daily treatment adherence, in the presence of a time-varying confounder (daily stress). Daily stress was due to social contextual factors but not affected by the exposure. Within its scope, this study serves as a preliminary framework for studying the causal structure of time-varying bio-behavioral processes.

  • Open Access

    Postpartum Weight Retention and Mortality Over 50 Years of Follow-up

    by Yajnaseni Chakraborti, Sunni L. Mumford, Edwina H. Yeung, Katherine L. Grantz, Pauline Mendola, James L. Mills, Ellen C. Caniglia, Colleen Bresinger, Cuilin Zhang, Enrique F. Schisterman, et al.

    Objective: This study aimed to evaluate the link between postpartum weight retention (PPWR) and long-term mortality. Methods: In this secondary analysis of 8165 women with ≥2 pregnancies in the Collaborative Perinatal Project (U.S., 1959–1966) with vital status follow-up through 2016, we used interpregnancy weight change (IPWC) and postpartum weight change (PPWC) as proxies of PPWR. IPWC was defined as the difference between self–reported pre–pregnancy weights from the 1st and 2nd CPP pregnancies, while PPWC was the difference between weight recorded at delivery of the 1st and prepregnancy weight of the 2nd CPP pregnancies. All–cause and cause–specific mortality models were adjusted for sociodemographic, behavioral, clinical, and pregnancy related characteristics from the 1st CPP pregnancy. Results: Compared to women with IPWC >0 to 1.8 kg (quintile 3), those with IPWC > −1.4 to 0 kg (quintile 2) had a lower risk of all-cause mortality [aHR (95% CI): 0.85 (0.76–0.96)], with the most notable reduction observed in diabetes-related risk of mortality [aHR (95% CI): 0.45 (0.23–0.87)]. Lower quintiles of PPWC (i.e., greater weight loss) were linked to reduced all–cause and cause–specific risk of mortality, though estimates were imprecise. Conclusions: Modest PPWR was linked with increased mortality risk over 50 years of follow-up.

  • Preconception Chlamydia trachomatis seropositivity and fecundability, live birth, and adverse pregnancy outcomes

    by Yajnaseni Chakraborti, Stefanie N. Hinkle, Jørgen Skov Jensen, Catherine L. Haggerty, Toni Darville, Sunni L. Mumford, Enrique F. Schisterman, Robert M. Silver, Brandie DePaoli Taylor


  • Estimating generalized propensity scores with survey and attrition weighted data

    by Daniel F. McCaffrey, Beth Ann Griffin, Michael Robbins, Yajnaseni Chakraborti, Donna L. Coffman, Brian Vegetabile

    Prior work in causal inference has shown that using survey sampling weights in the propensity score estimation stage and the outcome model stage for binary treatments can result in a more robust estimator of the effect of the binary treatment being analyzed. However, to date, extending this work to continuous treatments and exposures has not been explored nor has consideration been given for how to handle attrition weights in the propensity score model. Nonetheless, generalized propensity score (GPS) analyses are being used for estimating continuous treatment effects on outcomes when researchers have observational data, and those data sets often have survey or attrition weights that need to be accounted for in the analysis. Here, we extend prior work and show with analytic results that using survey sampling or attrition weights in the GPS estimation stage and the outcome model stage for continuous treatments can result in a more robust estimator than one that does not. Simulation study results show that, although using weights in both estimation stages is sufficient for robust estimation, it is not necessary and unbiased estimation is possible in some cases under various approaches to using weights in estimation. Analysts do not know if the conditions of our simulation studies hold, so use of weights in both estimation stages might provide insurance for reducing potential bias. We discuss the implications of our results in the context of an empirical example.


  • A Causal Approach to Functional Mediation Analysis with Application to a Smoking Cessation Intervention

    by Donna L. Coffman, John J. Dziak, Kaylee Litson, Yajnaseni Chakraborti, Megan E. Piper, Runze Li

    The increase in the use of mobile and wearable devices now allows dense assessment of mediating processes over time. For example, a pharmacological intervention may have an effect on smoking cessation via reductions in momentary withdrawal symptoms. We define and identify the causal direct and indirect effects in terms of potential outcomes on the mean difference and odds ratio scales, and present a method for estimating and testing the indirect effect of a randomized treatment on a distal binary variable as mediated by the nonparametric trajectory of an intensively measured longitudinal variable (e.g., from ecological momentary assessment). Coverage of a bootstrap test for the indirect effect is demonstrated via simulation. An empirical example is presented based on estimating later smoking abstinence from patterns of craving during smoking cessation treatment. We provide an R package, funmediation, available on CRAN at https://cran.r-project.org/web/packages/funmediation/index.html, to conveniently apply this technique. We conclude by discussing possible extensions to multiple mediators and directions for future research.